DOBUTAMINE IN THE MANAGEMENT OF DECOMPENSATED HEART FAILURE: EVIDENCE AND CLINICAL IMPLICATIONS FROM A LITERATURE REVIEW

Read full text Summarise with VIRAT
Authors: Bárbara Vilanova Bezerra, Mateus Vilanova Bezerra
Cited by: 0
References: 5

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Decompensated heart failure represents a clinical condition with high morbidity and mortality, often associated with reduced cardiac output and tissue hypoperfusion, requiring rapid therapeutic interventions to achieve hemodynamic stabilization. In this context, the use of inotropic agents such as dobutamine plays an important role in the management of patients with cardiovascular instability. This study aims to analyze, through a literature review, the main hemodynamic effects of dobutamine in the treatment of decompensated heart failure, as well as to discuss its clinical indications, therapeutic benefits, and potential limitations. To this end, a bibliographic review was conducted using the PubMed, SciELO, and LILACS databases, considering publications between 2013 and 2024, resulting in the final selection of 13 studies addressing the use of dobutamine in the management of heart failure. The findings indicate that dobutamine significantly improves myocardial contractility and increases cardiac output, contributing to hemodynamic stabilization in patients with acute heart failure. However, the literature also highlights potential limitations associated with prolonged use, including the risk of arrhythmias and increased myocardial oxygen consumption. It can be concluded that dobutamine remains an important therapeutic option in the management of decompensated heart failure, particularly in situations requiring rapid hemodynamic intervention, and its use should be carefully monitored and clinically indicated.

Fields of Study & Subjects

Heart Failure Treatment and Management Mechanical Circulatory Support Devices Cardiovascular Function and Risk Factors

Publication details

Journal / source
Seven Editora eBooks
Publication date
26 March 2026
Language
EN
Document type
Book chapter